Despite assurances from President Donald Trump’s administration in January that the coronavirus outbreak in the country is under control, new COVID cases in the country continued to rise. In fact, the U.S. is now the leading country in terms of the number of confirmed infections after surpassing China and Italy last week.
The recent development did not escape Hillary Clinton who has been consistently critical of President Donald Trump’s handling of the coronavirus pandemic. On Friday, the former Secretary of State took to Twitter mocking her former campaign rival and linking his “America First” slogan to the current top spot the U.S. occupies in terms of COVID-19 cases, according to Newsweek.
“He did promise ‘America First,’” Clinton tweeted. She also shared a New York Times article that reported how the U.S. became the country hardest hit by the coronavirus pandemic on Thursday.
There are now more than 150 thousand people confirmed to be infected with the virus in the U.S. There are now more than 2,800 reported deaths due to the virus.
Trump used the “America First” slogan during his 2016 campaign against Clinton. “We assembled here today are issuing a new decree to be heard in every city, in every foreign capital, and in every hall of power,” Trump said in his January 2017 inaugural address. “From this day forward, a new vision will govern our land. From this moment on, it's going to be America First.”
Clinton also criticized Trump for contradicting medical experts. “A month ago, Trump said: ‘It’s going to disappear. One day, it’s like a miracle, it will disappear,’” she wrote on a different post. “Yesterday, he said: ‘I don’t believe you need 40,000 or 30,000 ventilators.’ What will it take to get @realdonaldtrump to listen to experts instead of his own hunches?”
The former Secretary of State also criticized Trump’s response to the pandemic. “The Trump administration was told in January that coronavirus was likely to become a pandemic,” she wrote in a tweet last week. “They refused to act for fear of spooking the markets, losing weeks of time to prepare that we won't get back.”


Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
U.S. House Advances GOP Healthcare Bill as ACA Subsidies Near Expiration
Trump Announces $1,776 Cash Bonus for U.S. Military Personnel Ahead of Christmas
Trump Administration Plans Major Increase in Denaturalization Cases for Naturalized U.S. Citizens
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Federal Appeals Court Allows Trump’s National Guard Deployment in Washington, D.C. to Continue
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Federal Judge Declines to Immediately Halt Trump’s $300 Million White House Ballroom Project
Pakistan’s Army Chief Faces Gaza Troop Dilemma Amid US Pressure
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Dan Bongino to Step Down as FBI Deputy Director After Brief, Controversial Tenure
Taiwan Political Standoff Deepens as President Lai Urges Parliament to Withdraw Disputed Laws
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Sydney Bondi Beach Shooting Sparks Calls for Stronger Protection of Jewish Community in Australia
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



